Avantor (AVTR) – Analysts’ Recent Ratings Updates

A number of research firms have changed their ratings and price targets for Avantor (NYSE: AVTR):

• 7/15/2026 – Avantor had its “hold” rating reaffirmed by TD Cowen.
• 7/8/2026 – Avantor had its price target raised by Citigroup Inc. from $9.00 to $11.00. They now have a “neutral” rating on the stock.
• 7/6/2026 – Avantor was given a new $10.50 price target by Evercore Inc.
• 6/27/2026 – Avantor was upgraded by Wall Street Zen from “hold” to “buy”.
• 6/26/2026 – Avantor is now covered by Sanford C. Bernstein. They set a “market perform” rating and a $10.50 price target on the stock.
• 6/25/2026 – Avantor was upgraded by Sanford C. Bernstein to “hold”.
• 6/24/2026 – Avantor was given a new $8.00 price target by UBS Group AG.
• 6/24/2026 – Avantor had its price target raised by Barclays PLC from $7.00 to $8.00. They now have an “underweight” rating on the stock.
• 6/1/2026 – Avantor was downgraded by Wolfe Research to “underperform”. They now have a $7.00 price target on the stock.
• 6/1/2026 – Avantor was upgraded by Wolfe Research to “strong sell”.
• 5/30/2026 – Avantor was downgraded by Wall Street Zen from “buy” to “hold”.

Insider Activity

In related news, Director Gregory T. Lucier acquired 10,000 shares of the stock in a transaction dated Friday, May 8th. The stock was purchased at an average cost of $8.32 per share, with a total value of $83,200.00. Following the completion of the purchase, the director directly owned 60,000 shares in the company, valued at $499,200. This trade represents a 20.00% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Simon Dingemans bought 25,000 shares of the company’s stock in a transaction dated Friday, May 1st. The stock was bought at an average price of $8.14 per share, for a total transaction of $203,500.00. Following the acquisition, the director directly owned 25,000 shares of the company’s stock, valued at approximately $203,500. This represents a ∞ increase in their ownership of the stock. The SEC filing for this purchase provides additional information. 0.28% of the stock is currently owned by company insiders.

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.